Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, California, USA.
PLoS Genet. 2013;9(2):e1003293. doi: 10.1371/journal.pgen.1003293. Epub 2013 Feb 7.
Malaria parasites elude eradication attempts both within the human host and across nations. At the individual level, parasites evade the host immune responses through antigenic variation. At the global level, parasites escape drug pressure through single nucleotide variants and gene copy amplification events conferring drug resistance. Despite their importance to global health, the rates at which these genomic alterations emerge have not been determined. We studied the complete genomes of different Plasmodium falciparum clones that had been propagated asexually over one year in the presence and absence of drug pressure. A combination of whole-genome microarray analysis and next-generation deep resequencing (totaling 14 terabases) revealed a stable core genome with only 38 novel single nucleotide variants appearing in seventeen evolved clones (avg. 5.4 per clone). In clones exposed to atovaquone, we found cytochrome b mutations as well as an amplification event encompassing the P. falciparum multidrug resistance associated protein (mrp1) on chromosome 1. We observed 18 large-scale (>1 kb on average) deletions of telomere-proximal regions encoding multigene families, involved in immune evasion (9.5×10(-6) structural variants per base pair per generation). Six of these deletions were associated with chromosomal crossovers generated during mitosis. We found only minor differences in rates between genetically distinct strains and between parasites cultured in the presence or absence of drug. Using these derived mutation rates for P. falciparum (1.0-9.7×10(-9) mutations per base pair per generation), we can now model the frequency at which drug or immune resistance alleles will emerge under a well-defined set of assumptions. Further, the detection of mitotic recombination events in var gene families illustrates how multigene families can arise and change over time in P. falciparum. These results will help improve our understanding of how P. falciparum evolves to evade control efforts within both the individual hosts and large populations.
疟原虫在人体宿主和国家之间的根除尝试中都能逃避。在个体水平上,寄生虫通过抗原变异逃避宿主免疫反应。在全球范围内,寄生虫通过单核苷酸变异和基因拷贝扩增事件逃避药物压力,这些事件赋予了药物抗性。尽管它们对全球健康至关重要,但这些基因组改变出现的速度尚未确定。我们研究了在有或没有药物压力的情况下,经过一年无性繁殖的不同恶性疟原虫克隆的完整基因组。全基因组微阵列分析和下一代深度重测序(总计 14 太字节)的组合揭示了一个稳定的核心基因组,只有 38 个新的单核苷酸变异出现在 17 个进化克隆中(每个克隆平均 5.4 个)。在暴露于阿托伐醌的克隆中,我们发现了细胞色素 b 突变以及包含在 1 号染色体上的疟原虫多药耐药相关蛋白 (mrp1) 的扩增事件。我们观察到了 18 个涉及免疫逃避的多基因家族的端粒近端区域的大片段缺失(每个碱基对每代平均 1.85×10(-6) 结构变异)。其中 6 个缺失与有丝分裂过程中产生的染色体交叉有关。我们发现,遗传上不同的菌株之间以及在有或没有药物培养的寄生虫之间,这些突变率的差异很小。使用这些衍生的疟原虫突变率(每个碱基对每代 1.0-9.7×10(-9) 个突变),我们现在可以在一组明确的假设下模拟药物或免疫抗性等位基因出现的频率。此外,在 var 基因家族中检测到有丝分裂重组事件说明了多基因家族如何在恶性疟原虫中随时间而出现和变化。这些结果将有助于我们更好地理解恶性疟原虫如何在个体宿主和大人群中逃避控制努力而进化。